Published in J Hum Hypertens on May 01, 2003
Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging (2010) 1.13
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation (2016) 0.84
Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects. Vasc Health Risk Manag (2006) 0.82
Insulin resistance and vascular remodelling, in relation to left ventricular mass, geometry and function: an answer to LIFE? J Hum Hypertens (2003) 0.81
"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension (1990) 3.30
Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol (1999) 2.98
Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin Sci (1973) 2.52
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01
Home blood pressure monitoring. Arch Intern Med (2000) 1.71
Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation (2001) 1.69
High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62
Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med (1998) 1.57
Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57
The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol (2001) 1.55
Haemochromatosis genotype and iron overload: association with hypertension and left ventricular hypertrophy. J Intern Med (2010) 1.49
Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens (2005) 1.49
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens (2001) 1.49
Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48
Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med (1982) 1.45
Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest (1996) 1.45
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. J Hum Hypertens (2008) 1.44
Childhood traumas and psychosocial characteristics of 50-year-old men with essential hypertension. J Psychosom Res (1990) 1.42
Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men. J Intern Med (2011) 1.40
Cardiovascular reactivity, coronary risk factors, and sympathetic activity in young men. Hypertension (1993) 1.39
A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk (2001) 1.30
Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29
Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: The Hypertension Genetic Epidemiology Network Study . Hypertension (2001) 1.29
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28
Exercise blood pressure predicts cardiovascular mortality in middle-aged men. Hypertension (1994) 1.25
Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Network. Am J Hypertens (2001) 1.24
Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation (1971) 1.23
Influence of age on the hemodynamic response to exercise. Circulation (1967) 1.22
Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension (1997) 1.22
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. Hypertension (2000) 1.20
Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med (2001) 1.18
Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med (1977) 1.18
Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction. J Hypertens (2001) 1.17
The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens (1999) 1.15
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation (1971) 1.15
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study. J Hum Hypertens (2007) 1.14
Hemodynamic studies in patients with borderline blood pressure elevation. Circulation (1968) 1.11
Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens (1991) 1.10
Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation (1994) 1.10
Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation (1970) 1.10
Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension (2000) 1.10
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10
Exercise blood pressure predicts mortality from myocardial infarction. Hypertension (1996) 1.09
Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens (2013) 1.08
Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am J Cardiol (2000) 1.08
Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study. J Am Coll Cardiol (2000) 1.07
Easy money? Health cost savings resulting from the switch from a branded drug to a low-cost generic drug in the same class. Int J Clin Pract (2011) 1.07
Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey. J Hypertens (1998) 1.07
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension (2000) 1.07
Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens (1997) 1.06
Awareness of hypertension increases blood pressure and sympathetic responses to cold pressor test. Am J Hypertens (1990) 1.05
Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population. J Hum Hypertens (2007) 1.04
The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03
Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med (1972) 1.03
Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens (2000) 1.02
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest (1987) 1.02
Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol Ther (1977) 1.01
Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol (1975) 1.01
Borderline hypertension--a critical review. J Chronic Dis (1971) 1.00
Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol (2001) 1.00
Assessment of coronary risk in general practice in relation to the use of guidelines: a survey in Denmark. Prev Med (2001) 1.00
Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects. Hypertension (1996) 1.00
The effect of potassium chloride and spironolactone on the thiazide-induced potassium depletion in patients with essential hypertension. Acta Med Scand (1974) 0.99
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension (1998) 0.99
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Am J Hypertens (2001) 0.99
Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). Am J Cardiol (2001) 0.98
Left ventricular systolic dysfunction in a biracial sample of hypertensive adults: The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension (2001) 0.98
Influence of hypertension on the hemodynamic response to exercise. Circulation (1967) 0.97
Clinical characteristics and role of early cardiac magnetic resonance imaging in patients with suspected ST-elevation myocardial infarction and normal coronary arteries. Int J Cardiovasc Imaging (2010) 0.97
Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study. J Hum Hypertens (2012) 0.97
Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey. J Hum Hypertens (2008) 0.96
Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study. J Hypertens (2001) 0.95
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint. Am J Cardiol (2001) 0.94
Racial differences in erythrocyte cation transport. Hypertension (1984) 0.93
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood Press (1998) 0.92
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study. J Intern Med (2007) 0.92
Effect of home blood pressure and gender on estimates of the familial aggregation of blood pressure. The Tecumseh Blood Pressure Study. Hypertension (1992) 0.92
Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines. N Engl J Med (1982) 0.92